Antibodies News and Research

RSS

Researchers invent graphene-based biosensor to detect stomach-cancer causing bacteria

Biosensors are currently used in healthcare to monitor blood glucose; however, they also have the potential to detect bacteria.

20 Jun 2019

New chief medical officer appointed for Cancer Research UK’s Centre for Drug Development

Professor Peter Johnson will be the new chief medical officer for Cancer Research UK’s Centre for Drug Development, it was announced today (Tuesday).

19 Jun 2019

First commercial ChIP kit range released for Drosophila

Porvair Sciences has introduced the first commercial ChIP kit range dedicated to Drosophila.

From Chromatrap® - Porvair Sciences Ltd 19 Jun 2019

ChIP-seq kit maximizes chromatin-antibody binding and capture

Optimizing protein orientation for maximum chromatin-antibody binding and capture enables Chromatrap® ChIP-seq kits to offer market leading sensitivity.

From Chromatrap® - Porvair Sciences Ltd 19 Jun 2019

Scientists develop universal FACS-based approach to heterogenous cell sorting, propelling organoid research

Researchers have developed three novel FACS protocols that can be used to isolate neural progenitors, astrocytes, and neurons from infected cerebral organoids.

19 Jun 2019

Novel microfluidic device captures and isolates circulating tumor cell clusters

Cancer touches nearly everyone in one way or another, and regrettably, it will claim another 600,000 lives in the U.S. in 2019, according to the American Cancer Society. Researchers from San Diego State University, TumorGen MDx Inc., and Sanford Burnham Prebys Medical Discovery Institute set out to explore a seemingly basic question: What is it about cancer that kills?

19 Jun 2019

TEST-1 Using SPR to Confront the Antibody Reproducibility Crisis

It is important to validate parameters of purchased antibodies with SPR to ensure they are high-quality and also useful for your application,

From Nicoya Lifesciences 19 Jun 2019

Researchers discover redundancies in immune cells

Researchers at ETH Zurich have discovered redundancies in the biochemical signaling pathways of immune cells. This finding has important implications for advances in cancer immunotherapy, among other areas.

18 Jun 2019

Breastmilk antibody necessary to prevent necrotizing enterocolitis in preterm infants

A new study from the University of Pittsburgh and UPMC Children's Hospital of Pittsburgh finds that an antibody in breastmilk is necessary to prevent necrotizing enterocolitis (NEC)- an often deadly bacterial disease of the intestine-in preterm infants.

17 Jun 2019

Researchers develop DNA nanorobots that target breast cancer cells

According to the Mayo Clinic, about 20% of breast cancers make abnormally high levels of a protein called human epidermal growth factor receptor 2 (HER2).

17 Jun 2019

A 'homing beacon' for cancer drugs

Killing tumor cells while sparing their normal counterparts is a central challenge of cancer chemotherapy. If scientists could put a “homing beacon” in tumors, they could attract these medicines and reduce side effects caused by the drugs acting on healthy cells.

17 Jun 2019

Novel insight could improve vaccines that protect pregnant women and newborns

A team led by Duke Health scientists has identified a cellular process that could lead to the development of safer and more effective vaccines that protect pregnant women as well as their newborns from dangerous infections.

16 Jun 2019

Research suggests new way to improve the efficacy of arthritis drug

Attaching a removable lock to an arthritis drug can make it safer and more effective, according to a new study publishing June 13 in the open-access journal PLOS Biology led by Wen-Wei Lin of Kaohsiung Medical University, Taiwan.

From PLOS ONE 14 Jun 2019

Researchers uncover new mechanism by which cells communicate in inflammatory processes

A research group from MedUni Vienna and CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences has discovered a new mechanism by which cells communicate in inflammatory processes.

14 Jun 2019

Developing new immunotherapeutic treatments for emerging viral diseases

Emerging viral diseases is a term used to refer to diseases caused by pathogens such as the Ebola virus. Whilst vaccines can protect people against these diseases, there is an urgent need for treatment options after infection.

14 Jun 2019

New small drug-targeting molecules may improve cancer treatment

Researchers from the University of Notre Dame have developed small drug-targeting molecules that may be hundreds to thousands of times more effective at delivering potent drugs to desired sites of disease, including cancer.

14 Jun 2019

Ebola spread to Uganda could threaten international health

After smouldering in the Democratic Republic of Congo (DRC) for almost a year, killing near 1,000 people, the deadly Ebola virus crossed the border to Uganda in June 2019. This virus causes sudden high fever and sore throat, with severe weakness and muscle pain.

14 Jun 2019

Antibodies could cause arthritic pain

Antibodies that exist in the joints before the onset of rheumatoid arthritis can cause pain even in the absence of arthritis, researchers from Karolinska Institutet in Sweden report.

13 Jun 2019

Scientists turn type A blood into universal type O, potentially doubling blood transfusion stocks

Researchers have developed a technique for turning type A blood into universal type O blood. The development could boost blood stocks dramatically.

13 Jun 2019

Norovirus structures could help develop therapeutics to fight food-borne illness

Noroviruses are a leading cause of food-borne illness outbreaks, accounting for 58% of all outbreaks and cause 685 million cases worldwide each year. There is no effective therapeutic against them. Having knowledge of the intricate structure of the outer layer of noroviruses, the capsid, which allows the virus to attach to its human host, could help in vaccine development.

13 Jun 2019

Antibodies News and Research

Researchers invent graphene-based biosensor to detect stomach-cancer causing bacteria

New chief medical officer appointed for Cancer Research UK’s Centre for Drug Development

First commercial ChIP kit range released for Drosophila

ChIP-seq kit maximizes chromatin-antibody binding and capture

Scientists develop universal FACS-based approach to heterogenous cell sorting, propelling organoid research

Novel microfluidic device captures and isolates circulating tumor cell clusters

TEST-1 Using SPR to Confront the Antibody Reproducibility Crisis

Researchers discover redundancies in immune cells

Breastmilk antibody necessary to prevent necrotizing enterocolitis in preterm infants

Researchers develop DNA nanorobots that target breast cancer cells

A 'homing beacon' for cancer drugs

Novel insight could improve vaccines that protect pregnant women and newborns

Research suggests new way to improve the efficacy of arthritis drug

Researchers uncover new mechanism by which cells communicate in inflammatory processes

Developing new immunotherapeutic treatments for emerging viral diseases

New small drug-targeting molecules may improve cancer treatment

Ebola spread to Uganda could threaten international health

Antibodies could cause arthritic pain

Scientists turn type A blood into universal type O, potentially doubling blood transfusion stocks

Norovirus structures could help develop therapeutics to fight food-borne illness

Immunology eBook

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest Life Science News